Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 234-239

  Malejczyk, J ^a,b   Malejczyk, M ^b,c   Breitburd, F ^c   Majewski, S ^b,c   Schwarz, A ^d   Expert Besancon N ^b   Jablonska, S ^c   Orth, G ^b   Luger, T A ^d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUT PASTEUR   (France)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Human papillomavirus; Soluble tumour necrosis factor receptor; Tumour cell growth; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL GROWTH; CELL TRANSFORMATION; CYTOTOXICITY; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; IMMUNOBLOTTING; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; TUMOR GROWTH; WART VIRUS;

EID: 0030016275     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.343     Document Type: Article

References (33)

1. ADERKA D, ENGELMANN H, HORNIK V, SKORNICK Y, LEVO Y, WALLACH D AND KUSHTAL G. (1991). Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res., 51, 5602-5607.
2. ALONSO S, MINTY A, BOURLET Y AND BUCKINGHAM M. (1983). Comparison of 3 actin coding sequences in the mouse: Evolutionary relationships between the actin gene of warm-blooded vertebrates. J. Mol. Evol., 167, 77-101.
3. BISHOP JM. (1991). Molecular themes in oncogenesis. Cell, 64, 235-248.
4. 1. Cancer Res., 50, 7324-7332.
5. BROCKHAUS M, SCHOENFELD H-J, SCHLAEGER E-J, HUNZIKER W, LESSLAUER W AND LOETSCHER H. (1990). Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl Acad. Sci. USA, 87, 3127-3131.
6. CROWE PD, VANARSDALE TL, GOODWIN RG AND WARE CF. (1993). Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol., 151, 6882-6890.
7. ENGELMANN H, ADERKA D, RUBINSTEIN M, ROTMAN D AND WALLACH D. (1989). A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem., 264, 11974-11980.
8. ENGELMANN H, NOVICK D AND WALLACH DL. ( 1990). Two tumor necrosis factor-binding proteins purified from human urine: Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem., 265, 1531-1536.
9. GRAY PW, BARRETT K, CHANTRY D, TURNER M AND FELDMANN M. (1990). Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc. Natl Acad. Sci. USA, 87, 7380-7384.
10. HOWLEY PM. (1991). Role of the human papillomaviruses in human cancer. Cancer Res., 51, 5019s-5022s.
11. JABLONSKA S, MAJEWSKI S AND MALEJCZYK J. (1989). HPV infection and immunological responses. In Genitoanal Papilloma Virus Infection, von Krogh G, Rylander E. (eds) pp. 289-331. Conpharm AG: Karlstad, Sweden.
12. JENSON B AND LANCASTER WD. (1990). Association of human papillomavirus with benign, premalignant and malignant anogenital lesions. In Papillomaviruses and Human Cancer, Pfister H. (ed.) pp. 11-43. CRC Press: Boca Raton, FL, USA.
13. KIVIAT NB AND KOUTSKY LA. (1993). Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and treatment. J. Natl Cancer Inst., 85, 934-935.
14. KOHNO T, BREWER MT, BAKER SL, SCHWARTZ PE, KING MW, HALE KK, SQUIRES CH, THOMPSON RC AND VANNICE JL. (1990). A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl Acad. Sci. USA, 87, 8331-8335.
15. KRAMER SM AND CARVER ME. (1986). Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods, 93, 201-206.
16. LANTZ M, GULLBERG U, NILSSON E AND OLSSON I. (1990). Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J. Clin. Invest., 86, 1396-1402.
17. MAJEWSKI S, HUNZELMANN N, NISCHT R, ECKES B, RUDNICKA L, ORTH G, KRIEG T AND JABLONSKA S. (1991). TGFβ-1 and TNFα expression in the epidermis of patients with epidermodysplasia verruciformis. J. Invest. Dermatol., 97, 862-867.
18. MALEJCZYK J, MALEJCZYK M, URBANSKI A, KÖCK A, JABLONSKA S, ORTH G AND LUGER TA. (1991). Constitutive release of IL-6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell. Immunol., 136, 155-164.
19. MALEJCZYK J, MALEJCZYK M, KÖCK A, URBANSKI A, MAJEWSKI S, HUNZELMANN N, JABLONSKA S, ORTH G AND LUGER TA. (1992). Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-α. J. Immunol., 149, 2702-2708.
20. MALEJCZYK J, MALEJCZYK M, MAJEWSKI S, BREITBURD F, LUGER TA, JABLONSKA S AND ORTH G. (1994). Increased tumorigenicity of human papillomavirus type 16-harboring keratinocytes is associated with resistance to endogenous tumor necrosis factor-α-mediated growth limitation. Int. J. Cancer., 56, 593-598.
21. NOPHAR Y, KEMPER O, BRAKEBUSCH C, ENGELMANN H, ZWANG R, ADERKA D, HOLTMANN H AND WALLACH D. (1990). Soluble forms of tumor necrosis factor receptors (TNF-Rs): the cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J., 9, 3269-3278.
22. PFISTER H. (1990). Immunobiology of papillomaviruses and prospects of vaccination. In Papillomaviruses and Human Cancer, Pfister H. (ed.) pp. 239-251. CRC Press: Boca Raton, FL, USA.
23. PORTEU F AND NATHAN C.(1990). Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med., 172, 599-607.
24. PORTEU F, BROCKHAUS M, WALLACH D, ENGELMANN H AND NATHAN C. (1991). Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem., 266, 18846-18853.
25. SASTRE-GARAU X, SCHNEIDER-MAUNOURY S, COUTURIER J AND ORTH G. (1990). Human papillomavirus type 16 DNA is integrated into chromosome region 12q14-q15 in a cell line derived from vulvar intraepithelial neoplasia. Cancer Genet. Cytogenet., 44, 243-251.
26. SCHNEIDER-MAUNOURY S, CROISSANT O AND ORTH G. (1987). Integration of human papillomavirus type 16 DNA sequences: A possible early event in the progression of genital tumors. J. Virol., 61, 3295-3298.
27. SCHNEIDER-MAUNOURY S, PEHAU-ARNAUDET G, BREITBURD F AND ORTH G. (1990). Expression of the human papillomavirus type 16 genome in SK-v cells, a line derived from a vulvar intraepithelial neoplasia. J. Gen. Virol., 71, 809-817.
28. SECKINGER P, ZHANG J-H, HAUPTMANN B AND DAYER J-M. (1990) Characterization of a tumor necrosis factor α (TNF-α) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc. Natl Acad. Sci. USA, 87, 5188-5192.
29. SMITH CA, DAVIS T, ANDERSON D, SOLAM L, BECKMANN MP, JERZY R, DOWER SK, COSMAN D AND GOODWIN RG. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019-1023.
30. STRAULI P, BARRETT AJ AND BAICI A. (eds) (1980). Proteinases and Tumor Invasion, Raven Press: New York.
31. WAAGE A, LIABAKK N, LIEN E, LAMVIK J AND ESPEVIK T. (1992). p 55 and p 75 tumor necrosis factor receptors in patients with chronic leukemia. Blood, 80, 2577-2583.
32. WOODWORTH CD, NOTARIO V AND DIPAOLO JA. (1990). Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol., 64, 4767-4775.
33. ZUR HAUSEN H. (1989). Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res., 49, 4677-4681.